Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 October 2023 | Story Samkelo Fetile
2023 UFS Thought-Leader Webinar Series

The University of the Free State (UFS) is pleased to present a panel discussion titled, Student protest action, politics, and higher education, which is part of the 2023 Thought-Leader Webinar Series. Join Prof Adam Habib and Dr Max Price for a discussion about their respective experiences in leadership positions during the #RhodesMustFall and #FeesMustFall student protest movements, the lessons learnt during these tumultuous times, and how these events continue to influence the current landscape in the higher education sector in South Africa and further afield. The discussion will reflect on their recent books Rebels and Rage: Reflecting on #FeesMustFall, and Statues and Storms, and will be facilitated by Prof Francis Petersen, the Vice-Chancellor and Principal of the UFS.


Date:   Tuesday 21 November 2023

Time: 13:00-14:30

Click to view document WATCH: vimeo.com/kovsies/tls23

For further information, contact Alicia Pienaar at pienaaran1@ufs.ac.za.


Some of the topics discussed by leading experts in 2022 included, Crime in South Africa – who is to blame; Are our glasses half full or half empty; What needs to be done to power up South Africa; A look into the future of South Africa. This year’s webinar series commenced with a discussion on Threats to South Africa’s stability and security challenges, followed by A culture of acceptance – is this South Africa’s greatest threat? and The need for a global and regional plan / approach to respond to the consequences of the Russia-Ukraine war.


Facilitator:

Prof Francis Petersen

Vice-Chancellor and Principal, UFS

 

Panellists:

Prof Adam Habib

Director: School of Oriental and African Studies, University of London

 

Dr Max Price

Emeritus Vice-Chancellor, University of Cape Town; academic and consultant

 

Bios of speakers:

 

Prof Adam Habib

Prof Adam Habib is an academic, researcher, activist, administrator, and well-known public intellectual. A Professor of Political Science, Prof Habib has more than 30 years of academic, research, and administration expertise, spanning five universities and multiple local and international institutions.

Prior to his appointment as Director of SOAS, he was Vice-Chancellor and Principal of the University of the Witwatersrand (Wits) in Johannesburg, South Africa between 2013 and 2020. He has also served as Deputy Vice-Chancellor of Research at the University of Johannesburg, Executive Director of Democracy and Governance at the Human Sciences Research Council, and as Director of the Centre for Civil Society and Professor of Development at the University of KwaZulu-Natal. He is widely published, including his two well-received monographs, South Africa's Suspended Revolution: Hopes and Prospects and Rebels and Rage: Reflecting on #FeesMustFall.

Prof Habib’s academic contributions resulted in his election to the American Academy of Arts and Sciences, in addition to serving as a fellow of both the African Academy of Sciences and the Academy of Science of South Africa. He also serves on the Council of the United Nations University.

 

Dr Max Price

Dr Max Price was appointed Vice-Chancellor of the University of Cape Town in July 2008, completing his ten-year term in June 2018. During the first seven years of his term, UCT experienced growth and success in research and teaching, as well as global recognition. This continued during the last three years but was overshadowed by the Rhodes Must Fall and Fees Must Fall protests during 2015 to 2017. Dr Price led the university through these storms and back to safe harbour in 2018.

Dr Price studied Medicine at the University of the Witwatersrand (Wits), during which time he became deeply involved in student politics, becoming SRC president a year after the Soweto uprising. He subsequently did a PPE degree at Oxford as a Rhodes Scholar. Following clinical work in academic and rural hospitals in South Africa, he gained a master’s degree in Community Health at the London School of Hygiene and Tropical Medicine, and then worked as an academic in the areas of health policy and economics, rural health services, and health science education.

He was dean of the Faculty of Health Sciences at Wits for ten years. He now consults in public health, higher education, strategic leadership, and advises foundations on grant making. He is currently a scholar in residence at the Atlantic Institute. He is the author of Statues and Storms: Leading through change, published in 2023.

News Archive

UFS cardiac team leading with project
2017-05-31

 Description: Cardiac team read more Tags: Cardiac team read more

Prof Peter Schultheiss of the Charité University in Berlin,
Germany, visited the Robert WM Frater Centre for
Cardiovascular Research at the UFS for a study regarding
cardiomyopathy, a significant cause of fatal heart failure
among Africans. From the left are Dr Glen Taylor,
Dr Danie Buys, Prof Makoali Makatoko,
Prof Schultheiss and Prof Francis Smit.
Photo: Rulanzen Martin

A team of cardiac doctors associated with the Robert WM Frater Cardiovascular Research Centre at the University of the Free State’s (UFS) Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.  

An Afrocentric research focus
Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.

“To date there is no curable treatment for this condition and 50% of patients that have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made where virus infections of the heart muscle or myocarditis have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.

International collaborations ensure success
According to Prof Smit, the project is being run in conjunction with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.

“We have been working on the project over the past 18 months and I have twice visited Prof Schultheiss in Germany. He is now visiting us in Bloemfontein. We have established a collaborative project focused on patients in central South Africa”.
Prof Schultheiss is a world leader regarding the diagnosis, pathology and treatment of dilating cardiomyopathy, says Prof Smit.

“He brings a lifetime of research experience to Bloemfontein and is internationally renowned as the father of myocardial or heart muscle biopsies.

“His pioneering work on the discipline has led to diagnostic accuracy that has induced purposeful and personalised treatment of dilating cardiomyopathy and has brought about dramatic changes in some subsets of patients’ life expectancy and their cure.”

Solving problems close to home
According to Prof Mokoali Makatoko, Head of the Department of Cardiology, there are more than 1500 new cases of heart failure identified annually at the Universitas Academic Hospital, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies the team hopes to treat viruses unique to Southern Africa as well as other underlying causes of dilating cardiomyopathy.”

Prof Stephen Brown, Head of Paediatric Cardiology at the Universitas Academic Hospital, says children suffering from this disease never reach a mature age and those under his supervision will also be undergoing these tests. Various other departments at the UFS will also participate in this project. Profs Makatoko and Brown did the first four endomyocardial biopsies under the management of Prof Schultheiss during the past week. The results will be available in the coming weeks after which the project will be officially launched and patient recruitment will start in earnest.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept